Trastuzumab for the treatment of HER2-positive metastatic gastric cancer: A NICE single technology appraisal

Eldon Spackman; Stephen Rice; Gill Norman; Dong Churl Suh; Alison Eastwood; Stephen Palmer

doi:10.1007/s40273-013-0023-z

Trastuzumab for the treatment of HER2-positive metastatic gastric cancer: A NICE single technology appraisal

Eldon Spackman, Stephen Rice, Gill Norman, Dong Churl Suh, Alison Eastwood, Stephen Palmer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	185-194
Number of pages	10
Journal	PharmacoEconomics
Volume	31
Issue number	3
DOIs	https://doi.org/10.1007/s40273-013-0023-z
State	Published - Mar 2013
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.1007/s40273-013-0023-z

Cite this

@article{974c10efd57949af90ba7338e761d116,

title = "Trastuzumab for the treatment of HER2-positive metastatic gastric cancer: A NICE single technology appraisal",

author = "Eldon Spackman and Stephen Rice and Gill Norman and Suh, {Dong Churl} and Alison Eastwood and Stephen Palmer",

year = "2013",

month = mar,

doi = "10.1007/s40273-013-0023-z",

language = "English",

volume = "31",

pages = "185--194",

journal = "PharmacoEconomics",

issn = "1170-7690",

number = "3",

}

TY - JOUR

T1 - Trastuzumab for the treatment of HER2-positive metastatic gastric cancer

T2 - A NICE single technology appraisal

AU - Spackman, Eldon

AU - Rice, Stephen

AU - Norman, Gill

AU - Suh, Dong Churl

AU - Eastwood, Alison

AU - Palmer, Stephen

PY - 2013/3

Y1 - 2013/3

UR - http://www.scopus.com/inward/record.url?scp=84876923691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876923691&partnerID=8YFLogxK

U2 - 10.1007/s40273-013-0023-z

DO - 10.1007/s40273-013-0023-z

M3 - Article

C2 - 23371465

AN - SCOPUS:84876923691

SN - 1170-7690

VL - 31

SP - 185

EP - 194

JO - PharmacoEconomics

JF - PharmacoEconomics

IS - 3

ER -

Trastuzumab for the treatment of HER2-positive metastatic gastric cancer: A NICE single technology appraisal

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this